FDC Limited is recalling approximately 118,104 bottles of Timolol Maleate Ophthalmic Solution USP, 0.5% (5mL), distributed by Rising Pharmaceuticals Inc. The recall is due to a container defect where a plastic spike from the cap becomes lodged inside the bottle's nozzle. This defect prevents the liquid medication from being dispensed, which may lead patients to miss their prescribed doses.
The defective container makes it impossible to get the solution out of the bottle. For patients relying on this medication to treat conditions like glaucoma or ocular hypertension, a blocked nozzle could lead to missed doses and poorly controlled eye pressure.
You have 2 options:
Manufactured by FDC Limited; Distributed by Rising Pharmaceuticals Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.